Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 283 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare Coeptis Therapeutics to similar companies based on the strength of its analyst recommendations, institutional ownership, risk, profitability, dividends, earnings and valuation. Insider and Institutional […]